JOSEPH FREEZE: Open Payments
NPI 1831608504 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 61 payments from 15 companies in 2025. Trend: 2023 $1,119 · 2024 $1,718 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $285 |
| ABBVIE INC. | 13 | $244 |
| Ardelyx, Inc. | 6 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Ipsen Biopharmaceuticals, Inc | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| QOL Medical, LLC | 2 | $54 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Madrigal Pharmaceuticals | 2 | $31 |
Products named: TREMFYA, CREON, IBSRELA, IQIRVO, SKYRIZI, DUPIXENT, ENTYVIO, Sucraid.
Industry payments across VA — which companies pay providers there.
